Coronavirus update: Moderna targets vaccine approval by year's end as reopenings continue

Most visited

1 year ago full article

share

All eyes were on Moderna, which sparked a big rally on Wall Street after announcing promising early trial data of a coronavirus vaccine that is the furthest along among U.S. biotechs in the race. ...Read More

200o

70%
Menu

Leave a Comment